Journals / Turkish Journal of Obstetrics and Gynecology / 2022 / Cilt: 19 - Sayı: 2

A clinical scoring system for the diagnosis of adenomyosis

Adenomiyozis tanısı için klinik bir skorlama sistemi

Pages
138–144
Publication Date
2022-11-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: A scoring system is developed to predict adenomyosis non-invasively based on clinical evaluation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To develop a scoring system using clinical evaluation methods to predict the presence of adenomyosis.
📊
Key Findings & Data:Materials and Methods: A cohort of 232 patients who underwent hysterectomy for benign gynecologic disorders was prospectively enrolled.
💡
Conclusion & Impact:Conclusion: A scoring system is developed to predict adenomyosis non-invasively based on clinical evaluation
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To develop a scoring system using clinical evaluation methods to predict the presence of adenomyosis. Materials and Methods: A cohort of 232 patients who underwent hysterectomy for benign gynecologic disorders was prospectively enrolled. A detailed anamnesis was obtained and physical/pelvic examinations with trans-vaginal ultrasound imaging were performed one day before the hysterectomy. The diagnosis of adenomyosis was based on histopathologic examination. Findings were compared between patients with (n=55) and without (n=166) adenomyosis. Factors associated with adenomyosis were assessed with regression analysis and odds ratios (OR) were calculated. The variables found to be significant were chosen for the scoring system. Receiver operating characteristic analysis was carried out to find the cut-off values for these variables. Results: Number of parity, dyspareunia and dysmenorrhea visual analogue scale (VAS) scores, age of menarche, presence of uterine tenderness and detection of heterogeneous myometrium and myometrial cysts during ultrasonography were found to be the significant parameters. OR for the presence of myometrial heterogeneity, myometrial cysts, uterine tenderness were 27.2, 3.6 and 9.3 respectively. Cut-off values were calculated; 3 for parity (OR=2.8), 13-years for menarche (OR=1.6), 2 for dyspareunia VAS scores (OR=1.9) and 4 for dysmenorrhea VAS scores (OR=1.2). The total sum of maximum OR that a patient can obtain was calculated as 47.6 and this value was assumed to predict the presence of adenomyosis 100%. The multiplication of the sum of the OR in a patient by 2.1 (100/47.2) was found to have a predictive ability for the presence of adenomyosis. Conclusion: A scoring system is developed to predict adenomyosis non-invasively based on clinical evaluation

Özet

Amaç: Klinik değerlendirme yöntemleri kullanılarak adenomiyozis varlığını öngörmeye yarayacak bir skorlama sistemi geliştirmek. Gereç ve Yöntemler: Benign hastalıkları için histerektomi yapılan 232 kişilik bir kohort prospektif olarak değerlendirildi. Tüm hastalara histerektomiden bir gün önce detaylı anamnez alınarak, fizik/pelvik muayeneler ile birlikte transvajinal ultrasonografik inceleme yapıldı. Adenomiyozis tanısı histopatolojik inceleme ile konuldu. Adenomiyozisi olan (n=55) ve olmayan (n=165) hastaların bulguları karşılaştırıldı. Adenomiyozis ile ilişkili olduğu bulunan faktörler regresyon analizi ile değerlendirildi ve olasılık oranları (OO) hesaplandı. Anlamlı bulunan değişkenler skorlama sistemi için kullanıldı. Bu değişkenlerin eşik değerlerinin bulunması için alıcı işlem karakteristikleri analizi kullanıldı. Bulgular: Parite sayısı, disparoni ve dismenore görsel analog ölçek (VAS) skorları, menarş yaşı, uterin hassasiyet varlığı ve ultrasonografik incelemede heterojen miyometriyum ile miyometriyal kistlerin görülmesi anlamlı parametreler olarak bulundu. Miyometriyal heterojenite, miyometriyal kist ve uterin hassasiyet varlığı için OO sırasıyla 27,2, 3,6 ve 9,3 olarak bulundu. Parite için 3 (OO=2,8), menarş için 13 yaş (OO=1,6), disparoni VAS skoru için 2 (OO=1,9) ve dismenore VAS skoru için 4 (OO=1,2) eşik değerler olarak hesaplandı. Bir kişinin alabileceği maksimum OO değerlerinin toplamı 47,6 olarak hesaplandı ve bu değerin adenomiyozis varlığını yüzde yüz öngöreceği kabul edidi. Bir hastadaki OO’nun toplamının 2,1 ile çarpılmasının (100/47,2) o hastada adenomiyozis varlığı için öngörücü bir yeteneğe sahip olduğu sonucuna ulaşıldı. Sonuç: Klinik değerlendirmeye dayalı olan, non-invaziv olarak adenomiyozisi tahmin etmek için bir skorlama sistemi geliştirilmiştir.

🔖

Cite This Article

GÜRSES, İ., DURUKAN, H., YILDIRIR, M., AYTAN, H. (2022). A clinical scoring system for the diagnosis of adenomyosis. Turkish Journal of Obstetrics and Gynecology, Cilt: 19 - Sayı: 2, 138–144. https://ajindex.com/articles/612863

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Yalaza C, Canacankatan N, Gürses İ, Aytan H, Taşdelen B. Altered VEGF, Bcl-2 and IDH1 expression in patients with adenomyosis. Arch Gynecol Obstet 2020;302:1221-7
  2. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis Fertil Steril 2017;108:483-90
  3. Struble J, Reid S, Bedaiwy M. Adenomyosis: A clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol 2016;23:164-85
  4. Krentel H, Cezar C, Becker S, Sardo ADS, Tanos V, Wallwiener M, et al. From clinical symptoms to MR imaging: diagnostic steps in adenomyosis. Biomed Res Int 2017:1514029
  5. Shwayder J, Sakhel K. Imaging for uterine myomas and adenomyosis. J Minim Invasive Gynecol 2014;21:362-76
  6. Dartmouth K. A systematic review with meta-analysis: the common sonographic characteristics of adenomyosis. Ultrasound 2014;22:148- 57
  7. Moghadam R, Lathi RB, Shahmohamady B, Saberi NS, Nezhat CH, Nezhat F, et al. Predictive value of magnetic resonance imaging in differentiating between leiomyoma and adenomyosis. JSLS 2006;10:216-9
  8. Dueholm M. Transvaginal ultrasound for diagnosis of adenomyosis: a review. Best Pract Res Clin Obstet Gynaecol 2006;20:569-82
  9. Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)- pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol 2017;40:68-81
  10. Puente JM, Fabris A, Patel J, Patel A, Cerrillo M, Requena A, et al. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol 2016;14:60
  11. Vannuccini S, Luisi S, Tosti C, Sorbi F, Petraglia F. Role of medical therapy in the management of uterine adenomyosis. Fertil Steril 2018;109:398-405
  12. Blanche MT, Durrheim K, Painter D. Research in Practice Applied Methods for Social Sciences, 2nd edn, 2006. University of Cape Town Pres, Cape Town
  13. Machin D, Campbell MJ, Tan SB, Tan SH. Sample Size Tables for Clinical Studies, 3rd edn, 2009. Wiley-Blackwell Publishing, Oxford, UK
  14. DeLoach LJ, Higgins MS, Caplan AB, Stiff JL. The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg 1998;86:102-6
  15. Margulies R, Miller L. Fruit size as a model for teaching first trimester uterine sizing in bimanual examination. Obstet Gynecol 2001;98:341- 4
  16. Reinhold C, McCarthy S, Bret PM, Mehio A, Atri M, Zakarian R, et al. Diffuse adenomyosis: comparison of endovagi